Dr. Ryan to speak at National RX Summit in Atlanta

BrightView’s Dr. Shawn Ryan is presenting at this year’s Rx Drug Abuse & Heroin Summit in Atlanta April 22-25th where professionals from across the country will come together to address the opioid epidemic. The Rx Drug Abuse & Heroin Summit is where solutions are formulated, stakeholders from Federal to family convene, and change begins. It is the annual gathering for stakeholders to discuss what’s working in prevention and treatment. Notable speakers in past years have included President Barack Obama in 2016, Congressmen Patrick Kennedy and Newt Gingrich in 2017, and President Bill Clinton and Counselor to the President, Kellyanne Conway in 2018. Be part of the international discussion on addressing the opioid crisis by attending the 2019 Rx Drug Abuse & Heroin Summit in Atlanta.

Dr. Ryan will present on Wednesday, April 24th from 8:15am-9:30am on the topic of Buprenorphine: An innovative tool for managing opioid use disorders in emergency departments.

A synopsis of the presentation is as follows:

Due to the lack of adequate treatment resources in our communities, patients are increasingly visiting the emergency department (ED) seeking treatment services for opioid use disorder (OUD). When left untreated, OUD is a disease that can have devastating consequences and is often fatal. Thus, it is critical that emergency clinicians are equipped with tools to manage patients with opioid use disorder. The use of medications, such as buprenorphine, has proven to be an effective intervention for OUD, substantially reducing mortality and increasing retention in treatment. In this session, members of the American College of Emergency Physicians (ACEP) and the American Society of Addiction Medicine (ASAM) will discuss the barriers to increasing access to this vital medication in EDs and how to leverage an innovative tool, a web/smart phone app, to help clinicians manage patients with OUD in the ED and save lives.

Learning Objectives:

  • Describe how the web/smart phone app clarifies the indications and contradictions for buprenorphine administration (and prescribing) in the ED.
  • Explain how using the web/smart phone app helps EDs to more safely discharge patients, improving the linkage to treatment.
  • Describe how the web/smart phone app clarifies rules and regulations related to buprenorphine, administration and prescribing in the ED, thus reducing barriers to initiation of medications for addiction treatment in the United States.